AzTrials
AzTrials

BDNFBDNF KinematicNCT07175831

Determination of BDNF Peak Time in Different Types of Exercises

A study testing Low-Intensity Continuous Training, Moderate intensity Interval training and High-Intensity Interval Training in people with BDNF and Lactate, run by Aksaray University Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Purpose The purpose of this study was to determine the peak point of BDNF following exercises of different intensities. Method This randomized crossover controlled trial aimed to examine the acute effects of three experimental conditions-high-intensity interval training, long-interval continuous training, and… Read more about this study

Who is it for?
Ages 18 to 25 years, men onlyHealthy volunteers can take part
Conditions the study is for
BDNF, Lactate, Exercise Intensity
What is being tested?
Low-Intensity Continuous Training, Moderate intensity Interval training and High-Intensity Interval Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 May 2025to 25 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Aged between 18 and 25 years
  • No known medical condition that prevents participation in exercise
  • Not currently using any pharmacological agents

Who cannot join

  • Experiencing any discomfort before, during, or after exercise
  • Current or past diagnosis of pharmacological or doping substance use
  • Engaging in regular exercise (more than 3 times per week) within the last 2 weeks
  • History of alcohol or substance addiction
  • Any other condition or factor that may prevent full participation in the study protocol

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Aksaray university

    Aksaray, Aksaray, 68000

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of Different Types of Exercise Intensities on Peak BDNF Oscillation Duration

Purpose The purpose of this study was to determine the peak point of BDNF following exercises of different intensities.

Method This randomized crossover controlled trial aimed to examine the acute effects of three experimental conditions-high-intensity interval training, long-interval continuous training, and low-intensity continuous training-on serum BDNF and blood lactate levels in healthy young adults aged 18-25 years.

Read more

All participants completed the three conditions in a randomized and counterbalanced manner. To ensure balanced exposure, they were assigned to one of three groups (n = 4 per group), each following a distinct condition order based on a Latin square design. This approach guaranteed that each session occurred equally across time points (sessions 1-3) and that the order minimized sequence effects by rotating the position of each condition relative to the others.

To control for potential carryover-particularly from elevated neurochemical responses following intense exercise (BDNF increases had been reported)-no two high-intensity sessions were scheduled consecutively. Where possible, higher- and lower-intensity protocols were alternated. Furthermore, a seven-day interval separated each session to reduce residual physiological or cognitive effects.

The trial protocol was developed in line with CONSORT and SPIRIT guidelines, including relevant extensions for within-subject designs and non-pharmacological interventions. Participants were blinded to the study hypothesis.

All exercise sessions were conducted in the morning (09:00-11:00) on a track and field pitch under the supervision of a certified strength and conditioning coach to ensure consistency and adherence to protocol. Participants were instructed to avoid strenuous activity for 48 hours prior, abstain from alcohol and caffeine for 24 hours, and obtain at least 7-8 hours of sleep before each session. Dietary habits and general lifestyle were kept unchanged throughout the study.

During the first visit, participants' body weight and body fat percentage were assessed using bioelectrical impedance analysis. Resting heart rate was then recorded, followed by administration of the Yo-Yo Intermittent Recovery Test Level 1 to determine maximal aerobic speed (MAS), aerobic capacity, and peak heart rate.

In the following four visits, each participant completed all experimental conditions. Each exercise session began with a standardized 10-minute warm-up, including light jogging, dynamic stretching, and movement preparation drills.

All exercise sessions were conducted on a standard track and field facility and lasted 40 minutes in total, consisting of a 10-minute standardized warm-up, 24 minutes of exercise, and a 5-minute recovery period. The exercise component was individually prescribed based on each participant's MAS, determined from the Yo-Yo Intermittent Recovery Test Level 1. All running distances were calculated individually using time × speed formulas based on each participant's MAS, ensuring workload equivalence across conditions.

High-intensity interval exercise (HIIE): Participants ran at 105-110% of their MAS for 15-second intervals, covering a pre-calculated distance during each bout. After each 15-second sprint, they rested passively for 15 seconds and returned to their starting point. This was repeated continuously for 5 minutes, constituting one set. A total of four 5-minute sets were completed, interspersed with 2,5-minute passive rest periods, yielding a total exercise time of 30 minutes.

Moderate-Intensity Continuous Exercise (MICE): Participants ran continuously for 30 minutes at 70% of their MAS without rest.

Low-Intensity Continuous Exercise (LICE): Participants ran continuously for 30 minutes at 50% of their MAS without rest.

Being tested
Low-Intensity Continuous Training, Moderate intensity Interval training, High-Intensity Interval Training
Keywords
BDNF, Peak Time, Exercise Intensity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low-Intensity Continuous TrainingBehavioural

    Also called LICE

    Participants ran continuously for 30 minutes at 50% of their MAS without rest.

  • Moderate intensity Interval trainingBehavioural

    Also called MICE

    Participants ran continuously for 30 minutes at 70% of their MAS without rest.

  • High-Intensity Interval TrainingBehavioural

    Also called HIIE

    Participants ran at 105-110% of their MAS for 15-second intervals, covering a pre-calculated distance during each bout. After each 15-second sprint, they rested passively for 15 seconds and returned to their starting point. This was repeated continuously for 5 minutes, constituting one set. A total of four 5-minute sets were completed, interspersed with 2,5-minute passive rest periods, yielding a total exercise time of 30 minutes.

Study groups in NCT07175831
Study groupRoleWhat they receive
Low-Intensity Continuous Training Group (n=4)ExperimentalNot described
Receives: Behavioral: Low-Intensity Continuous Training
Modarate-Intensity Interval Training Group (n=4)ExperimentalNot described
Receives: Behavioral: Moderate intensity Interval training
High-Intensity Interval Training Group (n=4)ExperimentalNot described
Receives: Behavioral: High-Intensity Interval Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. BDNF

    BDNF levels were measured using a Sunred brand ELISA kit from blood samples taken baseline and after exercise, and the results were reported in ng/mL units.

    Measured: • Baseline, Immediately After Exercise (Day 1), 5 minute After Exercise (Day 1), 15 minutes After Exercise (Day 1), 30 minutes After Exercise (Day 1), 45 minutes After Exercise (Day 1), and 60 minutes After Exercise (Day 1).

  2. Lactate

    Lactate levels were measured in millimoles per liter (mmol/L) from capillary/venous blood samples taken before and after exercise using a lactate analyzer.

    Measured: • Baseline, Immediately After Exercise (Day 1), 5 minute After Exercise (Day 1), 15 minutes After Exercise (Day 1), 30 minutes After Exercise (Day 1), 45 minutes After Exercise (Day 1), and 60 minutes After Exercise (Day 1).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2025
  2. Study start10 May 2025
  3. Primary completion20 May 2025
  4. Study completion25 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07175831
Sponsor's protocol ID
30.06/07.10
Other IDs
Ethics Committe
Acronym
BDNF Kinematic
Status last verified
Sep 2025
First submitted
9 Sep 2025
Last updated
18 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Birinci YZ, Pancar S, Simsek H, Soylu Y, Konuk K, Sahin S. Time-dependent comparison of serum BDNF responses following high-intensity interval exercise and moderate- and low-intensity continuous exercise in healthy young men. Sci Rep. 2026 Jan 31;16(1):6821. doi: 10.1038/s41598-026-37728-z.

    PubMed 41620464

Questions about this trial

What is this clinical trial studying?

A study testing Low-Intensity Continuous Training, Moderate intensity Interval training and High-Intensity Interval Training in people with BDNF and Lactate, run by Aksaray University Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

BDNF (time frame: • Baseline, Immediately After Exercise (Day 1), 5 minute After Exercise (Day 1), 15 minutes After Exercise (Day 1), 30 minutes After Exercise (Day 1), 45 minutes After Exercise (Day 1), and 60 minutes After Exercise (Day 1).). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07175831, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in